A researcher with Merck Pharmaceutical who helped develop the human papilloma virus (HPV) vaccines, Gardasil and Cervarix, has revealed that the controversial drugs will do little to reduce cervical cancer rates and may cause more illness than the disease they are intended to prevent.
Dr. Diane Harper, director of the Gynecologic Cancer Prevention Research Group at the University of Missouri, and lead researcher in the development of the two vaccines, made these remarks during an address at the 4th International Public Conference on Vaccination in Reston, Virginia on Oct. 2-4.
More...
